Targeting the hepatocyte growth factor–cMET axis in cancer therapy
GR Blumenschein Jr, GB Mills… - Journal of clinical …, 2012 - ascopubs.org
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
GR Blumenschein, GB Mills… - Journal of Clinical …, 2012 - cir.nii.ac.jp
抄録< jats: p> The hepatocyte growth factor (HGF) and its receptor, the transmembrane
tyrosine kinase cMET, promote cell proliferation, survival, motility, and invasion as well as …
tyrosine kinase cMET, promote cell proliferation, survival, motility, and invasion as well as …
Targeting the hepatocyte growth factor-cMET axis in cancer therapy
GR Blumenschein Jr, GB Mills… - Journal of clinical …, 2012 - pubmed.ncbi.nlm.nih.gov
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
Targeting the hepatocyte growth factor-cMET axis in cancer therapy
GR Blumenschein, GB Mills… - Journal of Clinical …, 2012 - mdanderson.elsevierpure.com
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
Targeting the hepatocyte growth factor-cMET axis in cancer therapy.
GR Blumenschein Jr, GB Mills… - Journal of Clinical …, 2012 - europepmc.org
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
Targeting the hepatocyte growth factor-cMET axis in cancer therapy
GR Blumenschein, GB Mills… - Journal of Clinical …, 2012 - ohsu.elsevierpure.com
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
[HTML][HTML] Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
GR Blumenschein Jr, GB Mills… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
[引用][C] Targeting the Hepatocyte Growth Factor―cMET Axis in Cancer Therapy
GR BLUMENSCHEIN, GB MILLS… - Journal of clinical …, 2012 - pascal-francis.inist.fr
Targeting the Hepatocyte Growth Factor―cMET Axis in Cancer Therapy CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
Targeting the hepatocyte growth factor-cMET axis in cancer therapy.
GR Blumenschein Jr, GB Mills… - Journal of Clinical …, 2012 - europepmc.org
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …
cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic …